Sperm vitality and necrozoospermia: Diagnosis, management, and results of a global survey of clinical practice
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessAttribution-NonCommercial 4.0 Internationalhttps://creativecommons.org/licenses/by-nc/4.0/Tarih
2022Yazar
Agarwal, AshokSharma, Rakesh K.
Gupta, Sajal
Boitrelle, Florence
Finelli, Renata
Parekh, Neel
Durairajanayagam, Damayanthi
Saleh, Ramadan
Arafa, Mohamed
Cho, Chak Lam
Farkouh, Ala’a
Rambhatla, Amarnath
Henkel, Ralf
Vogiatzi, Paraskevi
Tadros, Nicholas
Kavoussi, Parviz
Ko, Edmund
Leisegang, Kristian
Kandil, Hussein
Palani, Ayad
Salvio, Gianmaria
Mostafa, Taymour
Rajmil, Osvaldo
Banihani, Saleem Ali
Schon, Samantha
Le, Tan V.
Birowo, Ponco
Çeker, Gökhan
Alvarez, Juan
Molina, Juan Manuel Corral
Ho, Christopher C.K.
Calogero, Aldo E.
Khalafalla, Kareim
Duran, Mesut Berkan
Kuroda, Shinnosuke
Colpi, Giovanni M.
Zini, Armand
Anagnostopoulou, Christina
Pescatori, Edoardo
Chung, Eric
Caroppo, Ettore
Dimitriadis, Fotios
Pinggera, Germar-Michael
Busetto, Gian Maria
Balercia, Giancarlo
Elbardisi, Haitham
Taniguchi, Hisanori
Park, Hyun Jun
Rosas, Israel Maldonado
de la Rosette, Jean J. M. C. H.
Ramsay, Jonathan
Bowa, Kasonde
Simopoulou, Mara
Rodriguez, Marcelo Gabriel
Sabbaghian, Marjan
Martinez, Marlon
Gilani, Mohamed Ali Sadighi
Al-Marhoon, Mohamed S.
Kosgi, Raghavender
Cannarella, Rossella
Micic, Sava
Fukuhara, Shinichiro
Parekattil, Sijo
Jindal, Sunil
Abdel-Meguid, Taha Abo-Almagd
Morimoto, Yoshiharu
Shah, Rupin
Üst veri
Tüm öğe kaydını gösterKünye
Agarwal, A., Sharma, R. K., Gupta, S., Boitrelle, F., Finelli, R., Parekh, N. ... Shah, R. (2022). Sperm vitality and necrozoospermia: Diagnosis, management, and results of a global survey of clinical practice. World Journal of Men's Health, 40(2), 228-242. https://dx.doi.org/10.5534/wjmh.210149Özet
Sperm vitality testing is a basic semen examination that has been described in the World Health Organization (WHO) Laboratory Manual for the Examination and Processing of Human Semen from its primary edition, 40 years ago. Several methods can be used to test sperm vitality, such as the eosin-nigrosin (E-N) stain or the hypoosmotic swelling (HOS) test. In the 6th (2021) edition of the WHO Laboratory Manual, sperm vitality assessment is mainly recommended if the total motility is less than 40%. Hence, a motile spermatozoon is considered alive, however, in certain conditions an immotile spermatozoon can also be alive. Therefore, the differentiation between asthenozoospermia (pathological decrease in sperm motility) and necrozoospermia (pathological decrease in sperm vitality) is important in directing further investigation and management of infertile patients. The causes leading to necrozoospermia are diverse and can either be local or general, testicular or extra -testicular. The andrological management of necrozoospermia depends on its etiology. However, there is no standardized treatment available presently and practice varies among clinicians. In this study, we report the results of a global survey to understand current practices regarding the physician order of sperm vitality tests as well as the management practices for necrozoospermia. Laboratory and clinical scenarios are presented to guide the reader in the management of necrozoospermia with the overall objective of establishing a benchmark ranging from the diagnosis of necrozoospermia by sperm vitality testing to its clinical management.